MAPT and Cognitive impairment: Immunization of 12-month-old female 3×Tg-AD mice with 43D and 77E9 antibodies once weekly for 6 weeks rescued cognitive impairment, and the beneficial effect on cognitive improvement lasted at least 3 months after discontinuation of the treatment with tau antibodies.